Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in pediatric bipolar I disorder (mania)
CTR20192263Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Pfizer. Started Dec 2019; status: terminated.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on CTR20192263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192263.